Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |